“…Compared with normal tissues, Rac3 mRNA levels were significantly overexpressed in BLCA, CESC, DLBC, HNSC, LIHC, LUAD, LUSC, OV, PAAD, PRAD, SKCM, THCA, THYM, UCEC, and UCS, while it was underexpressed in KIRC and LAML. The results were further supported by previous studies involving in bladder cancer [10], [11], lung adenocarcinoma [14], [38], breast cancer [39], [40], prostate carcinomas [41], brain tumors [42], colitis-associated cancer [43], and acute myeloid leukemia [44]. Moreover, the protein expression of Rac3 was highly expressed in lung cancer, head and neck cancer, liver cancer, urothelial cancer, breast cancer, cervical cancer, ovarian cancer, lymphoma, and skin cancer from the HPA database.…”